Advertisement

Topics

Onset Therapeutics Company Profile

19:33 EST 18th February 2019 | BioPortfolio

Onset Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of dermatology products formulated with the Company’s innovative proprietary topical formulation technologies and unique delivery systems. The Company utilizes its novel DELEVO® Foam Technology that is designed to deliver enhanced penetration of proven active ingredients in cosmetically elegant, hydrating formulations with the goal of enhancing patient compliance.


News Articles [977 Associated News Articles listed on BioPortfolio]

Young-Onset Type 2 Diabetes Tied to Increased Hospitalization Risk

TUESDAY, Jan. 15, 2019 -- Adults with young-onset type 2 diabetes (T2D; onset before age 40 years) have an increased hospitalization risk across their life span compared with those with usual-onset T2...

Epileptic #seizures can be classified as focal onset, generalized onset or unknown onset http://go.nature.com/2Gm1cMx  #epilepsypic.twitter.com/Ogp62R0DML

Epileptic #seizures can be classified as focal onset, generalized onset or unknown onset http://go.nature.com/2Gm1cMx  #epilepsy pic.twitter.com/Ogp62R0DML

A novel homozygous mutation of the TFG gene in a patient with early onset spastic paraplegia and later onset sensorimotor polyneuropathy

Early-Onset Group B Strep Infections Drop in U.S. Neonates (CME/CE)

(MedPage Today) -- Rates of late-onset GBS disease, however, have not decreased, and study finds other concerns

Type 1 Diabetes: The Earlier the Onset, the Worse the Prognosis

Data from a Swedish registry study emphasize the need to focus on early-onset patients' elevated cardiovascular risks and mortality.

Rates of Early-Onset Group B Strep Down Among U.S. Infants

(MedPage Today) -- But rates of late-onset GBS disease have remained stable

Medical News Today: Exercise could benefit early-onset Alzeimer's

New research supports the idea that physical activity delays cognitive decline and other changes in the rare early-onset form of Alzheimer's disease.

Genetic Basis of Early-Onset AF: The Case Titins

The presence of loss-of-function variants in a gene encoded for the sarcomeric protein titin was elevated in people with early-onset atrial fibrillation and no cardiomyopathy. Medscape Medical News

Drugs and Medications [28 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Oxygen [breathe easy therapeutics, inc]

NA

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [1169 Associated PubMed Articles listed on BioPortfolio]

Delayed Onset of Azacitidine-Associated Pneumotitis: A Case Report.

Young-onset multiple system atrophy: Clinical and pathological features.

The onset of multiple system atrophy (MSA) before age 40 years is referred to as "young-onset MSA." We identified clinical and pathological characteristics that might help with its early diagnosis and...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

A latent profile analysis of age of onset in pathological skin picking.

Pathological Skin Picking (PSP) may begin at any age, but the most common age of onset is during adolescence. Age of onset is a potentially useful clinical marker to delineate subtypes of psychiatric ...

Clozapine-Associated Pulmonary Embolism: A High-Mortality, Dose-Independent and Early-Onset Adverse Effect.

Recent epidemiological studies have identified an excess of pulmonary embolism (PE) cases in patients treated with antipsychotic drugs. The findings are particularly relevant for patients treated with...

Clinical Trials [1707 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease

We propose to build on preliminary data evaluating non-dopaminergic/non-motor clinical biomarkers to more fully assess these markers at the threshold of Parkinson disease (PD). Developmen...

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study

Type 2 diabetes (T2D) in youth is increasing in prevalence in parallel with the obesity epidemic. In the US, almost half of patients with renal failure have DKD, and ≥80% have T2D. Compa...

Companies [1343 Associated Companies listed on BioPortfolio]

Onset Therapeutics

Onset Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of dermatology products formulated with the Company’s innovative pro...

Onset Therapeutics LLC

Onset Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of dermatology products formulated with the Company’s innovative pro...

Onset Dermatologics, LLC

Onset Dermatologics, LLC is a wholly-owned subsidiary of Precision Dermatology, Inc. In addition to MINOCIN®, Onset Dermatologics markets the prescription brands Locoid®, ...

Onset Technology

Onset Technology provides Mobile Messaging Management solutions that ensure communication continuity in emergency situations when everything else fails. Additional Onset solutions...

Onset Dermatologics LLC

Headquartered in Cumberland RI, Onset Dermatologics LLC, a subsidiary of PreCision Dermatology, Inc., is a fully-integrated prescription dermatology company with a mission to deli...

More Information about "Onset Therapeutics" on BioPortfolio

We have published hundreds of Onset Therapeutics news stories on BioPortfolio along with dozens of Onset Therapeutics Clinical Trials and PubMed Articles about Onset Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Onset Therapeutics Companies in our database. You can also find out about relevant Onset Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record